{"schema_version":"secwatch.filing_event.v1","accession":"0001099800-26-000048","form_type":"8-K","ticker":"EW","cik":"0001099800","company_name":"Edwards Lifesciences Corp","filed_at":"2026-08-28T20:15:18+00:00","discovered_at":"2026-08-28T20:17:27.273761+00:00","generated_at":"2026-08-28T20:17:31.814805+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Edwards Lifesciences Strategy VP Donald Bobo to retire by mid-2027; successor search begins","bullets":["Donald E. Bobo, Jr., Corporate Vice President of Strategy and Corporate Development, plans to retire by mid-year 2027.","Board will begin a selection process promptly to identify a successor, with transition expected during 2027.","Bobo is expected to remain as a consultant with the Company through the end of 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001099800-26-000048","json":"https://secwatch.observer/filing/0001099800-26-000048.json","markdown":"https://secwatch.observer/filing/0001099800-26-000048.md","text":"https://secwatch.observer/filing/0001099800-26-000048.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1099800/000109980026000048/0001099800-26-000048-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1099800/000109980026000048/ew-20260825.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-28T20:17:31.814805+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}